Program Committee

Advanced NSCLC
  • Scott Laurie, Chair, Canada
    Honoraria:
    Novartis, Pfizer, Boehringer Ingelheim, AstraZeneca
    Other Relationships: Bristol-Myers Squibb, Novartis, Pfizer, Boehringer Ingelheim, AstraZeneca, BBI
  • Leora Horn, Co-Chair, USA
    Supported/Contracted Research/Gran
    t: Xcovery Holding Company, Bristol-Meyers Squibb, Boehringer Ingelheim, AbbVie, Genentech, Merck
    Other Relationships: AbbVie, AstraZeneca, Genentech, Merck, Incyte, Xcovery, Roche
  • Carlos Gil Ferreira, Brazil
    Nothing disclosed
  • Glen Goss, Canada
    Nothing disclosed
  • Pasi Jänne, USA
    Speakers or Advisory Board:
     AstraZeneca, Boehringer Ingelheim, Pfizer, Merrimack Pharmas, Roche, Genentech, Chugai Pharmas, Acea Biosciences, Ignyta, Loxo, Ariad, Eli Lilly, Araxes Pharmas
    Speakers Bureau: Loxo
    Supported/Contracted Research/Grant: Astellas Pharmas, AstraZenenca, Daiichi Sankyo, PUMA, Eli Lilly, Boehringer Ingelheim
    Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds): Gatekeeper Pharmas
    Royalty, Intellectual Property/Patent Holder: LabCorp
    Other Relationships: Araxes Pharmas, Ariad, AstraZeneca, Boehringer Ingelheim, Chugai, Ignyta, Eli Lilly, Loxo, Merrimack, Mirati Therapeutics, Pfizer, Roche, Dana-Farber Cancer Institute
  • Clarissa Mathias, Brazil
    Nothing disclosed
  • Keunchil Park, Korea
    Speakers or Advisory Board: AstraZeneca, Astellas, Boehringer Ingelheim, Bristol-Meyers Squibb, Clovis, Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, Hanmi, KHK, Merck, Novartis, Roche
    Supported/Contracted Research/Grant: AstraZeneca
    Other Relationships: Astellas Pharma, AstraZeneca, Boehringer Ingelheim, Clovis Oncology, Eli Lilly, Hanmi, Kyowa Kakko Kirin, Novartis, Ono Pharma, Roche, Bristol-Meyers Squibb, GlaxoSmithKline, Merck, GlaxoSmithKline
  • Suresh Ramalingam, USA
    Speakers or Advisory Board:
     AbbVie, Amgen, AstraZeneca, Bristol-Meyers Squibb, Celgene, Genentech, Roche, Nektar, Takeda, Loxo, Eli Lilly, Merck, Novartis
    Other Relationships: AbbVie, Amgen, AstraZeneca, Bristol-Meyers Squibb, Celgene, Genentech, Roche, Nektar, Takeda, Loxo, Eli Lilly, Merck, Novartis
  • Noemi Reguart, Spain
    Nothing disclosed
  • Christian Rolfo, Belgium
    Nothing disclosed
  • Qing Zhou, China
    Nothing disclosed
Advocacy
  • Paul Wheatley-Price, Chair, Canada
    Speakers or Advisory Board:
     AstraZeneca, Novartis, Eli Lilly Oncology, Bristol-Meyers Squibb, Merck, Takeda
  • Jesme Fox, Co-Chair, United Kingdom
    Nothing disclosed
  • Bonnie Addario, USA
    Nothing disclosed
  • Andrea Ferris, USA
    Nothing disclosed
  • Kazuo Hasegawa, Japan
    Nothing disclosed
  • Kim Norris, USA
    Speakers or Advisory Board:
    Takeda
    Other Relationships: Takeda
  • Silvia Novello, Italy
    Speakers or Advisory Board:
    Takeda
    Speakers Bureau: Boehringer Ingelheim, AstraZeneca, Roche, Merck, Bristol-Meyers Squibb, Eli Lilly, Takeda, Pfizer
  • Christina Sit, Canada
    Nothing disclosed
  • Jack (Howard) West, USA
    Speakers or Advisory Board:
     AbbVie, Ariad, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Merck, Roche, Genentech, Takeda, Spectrum
    Speakers Bureau: Ariad, Bristol-Myers Squibb, Eli Lilly
    Other Relationships: Ariad, Genentech, Roche, Takeda
Biology
  • Wan Lam, Chair, Canada
    Nothing disclosed
  • Kwok-kin Wong, Co-Chair, USA
    Nothing disclosed
  • Oscar Arrieta, Mexico
    Nothing disclosed
  • David Beer, USA
    Nothing disclosed
  • Robert Doebele, USA
    Honoraria:
     Pfizer, AstraZeneca, Ariad, Guardant Health, Takeda, Spectrum Pharmas, Trovagene
    Speakers or Advisory Board: Ignyta, AstraZeneca, Bayer, Takeda, Bristol-Meyers Squibb, Ariad
    Supported/Contracted Research/Grant: Ignyta
    Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds):
    Royalty, Intellectual Property/Patent Holder: Abbott Molecular, Rain Therapeutics, Igynta
    Other Relationships: Pfizer, OncoMed, Trovagene, Ignyta, GreenPeptide, AstraZeneca, Ignyta, Ariad, Guardant Health
  • Ramaswamy Govindan, USA
    Honoraria:
     AbbVie, Genentech, Boehringer Ingelheim
    Speakers or Advisory Board:
     Merck, Baxalta, Roche, Boehringer Ingleheim, Novartis, Pfizer, Celgene, AstraZeneca, MSK, AbbVie Inivata, Pfizer, NeoHealth, Bristol-Meyers Squibb, Nektar, GlaxcSmithKline
    Other Relationships: Genentech, Ariad, Astellas, Bristol-Meyers Squibb, INC Research, AbbVie
  • Fred R. Hirsch, USA
    Speakers or Advisory Board:
     AbbVie, AstraZeneca, Biocept, Bristol-Meyers Squibb, HTG, Eli Lilly, Loxo, Merck, Novartis, Pfizer, Roche, Genentech, Ventana, Bayer
    Supported/Contracted Research/Grant: Eli Lilly, Genentech, Amgen, Bristol-Meyers Squibb, Celgene
    Royalty, Intellectual Property/Patent Holder: University of Colorado Cancer Center
    Other Relationships: AstraZeneca, Genentech, HTG Molecular Diagnostics, Eli Lilly, Merck, Clovis Oncology, Ventana Medical Systems, Bristol-Meyers Squibb, Pfizer, Roche
  • Thomas John, Australia
    Speakers or Advisory Board:
     Bristol-Meyers Squibb, AstraZeneca, Boehringher Ingelheim, Takeda, Pfizer, Novartis, Merck, Ignyta
    Other Relationships: Bristol-Meyers Squibb, AstraZeneca, Boehringer Ingelheim, Takeda, Pfizer, Novartis, Merck
  • Geoffrey Liu, Canada
    Honoraria:
     AstraZeneca, Novartis, Takeda, Bristol-Meyers Squibb, AbbVie, Pfizer, Merck
    Speakers or Advisory Board: AstraZeneca, Roche, Merck, Novartis, Takeda, Bristol-Meyers Squibb, AbbVie
    Speakers Bureau: AstraZeneca
  • William Lockwood, Canada
    Nothing disclosed
  • Phil Mack, USA
    Speakers or Advisory Board:
     AstraZeneca, Eli Lilly, Pfizer
    Supported/Contracted Research/Grant: Boehringer Ingelheim
    Other Relationships: Guardant Health, Apton Biosystems
  • Matthew Meyerson, USA
    Speakers or Advisory Board:
    OrigiMed
    Supported/Contracted Research/Grant: Bayer
    Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds): OrigiMed
    Royalty, Intellectual Property/Patent Holder: LabCorp
  • Katerina Politi, USA
    Honoraria:
     AstraZeneca, Merck, Novartis, Tocagen
    Supported/Contracted Research/Grant: AstraZeneca, Roche, Kolltan, Symphogen
    Royalty, Intellectual Property/Patent Holder: Molecular MD
  • Daniel Tan, Singapore
    Honoraria:
     National Cancer Centre Singapore, Pfizer, Merck, AstraZeneca, Loxo, Boehringer Ingelheim, Bristol-Meyers Squibb
    Speakers or Advisory Board: AstraZeneca, Pfizer, Novartis, Merck
    Supported/Contracted Research/Grant: GSK, AstraZeneca, Novartis
  • Pan-Chyr Yang, Taiwan
    Nothing disclosed
Education
  • Barb Melosky, Chair, Canada
    Nothing disclosed
  • Alex Adjei, Co-Chair, USA
    Nothing disclosed
  • Michael Moyer, Australia
    Nothing disclosed
  • Ron Burkes, Canada
    Speakers or Advisory Board
    : AstraZeneca, Roche, Boehringer Ingelheim, Merck, Eli Lilly, Amgen
  • Federico Cappuzzo, Italy
    Nothing disclosed
  • Randeep Sangha, Canada
    Honoraria:
     Pfizer, Boehringer Ingelheim, AstraZeneca, Roche, Genentech, Lundbeck, Bristol-Meyers Squibb, Merck, AbbVie, Takeda
    Speakers or Advisory Board: Boehringer Ingelheim, AstraZeneca, Roche, Genentech, Lundbeck, Eli Lilly, Bristol-Meyers Squibb, Merck, Novartis, AbbVie, Takeda
    Other Relationships: Bristol-Meyers Squibb
  • Edgardo Santos, USA
    Speakers Bureau:
     Genentech, Pfizer, Novartis, Amgen, Takeda, Boehringer Ingelheim, Celgene, Merck, AstraZeneca
Immunooncology
  • Desiree Hao, Chair, Canada
    Nothing disclosed
  • Solange Peters, Co-Chair, Switzerland
    Speakers or Advisory Board
    : Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, Roche, Janssen, Merck, Pfizer, Regeneron, Takeda
  • Myung-Ja Ahn, Korea
    Speakers or Advisory Board:
     AstraZeneca, Eli Lilly, Bristol-Meyers Squibb, Merck, Ono Pharma, Roche
    Other Relationships: AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Merck, Novartis, Alpha BioPharmas
  • Fabrice Barlesi, France
    Honoraria:
     AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Clovis Oncology, Eli Lilly, Roche, Novartis, Merck, Pierre Fabre, Pfizer, Takeda, Serono
    Speakers or Advisory Board: AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Clovis Oncology, Eli Lilly, Roche, Novartis, Merck, Pierre Fabre, Pfizer, Takeda
    Supported/Contracted Research/Grant: AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Eli Lilly, Roche, Novartis, Merck, Pierre Fabre, Pfizer, Takeda
    Other Relationships: Roche, Genentech., AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Clovis, Eli Lilly, Roche, Novartis, Merck, Pierre Fabre, Pfizer, Takeda
  • Julie Brahmer, USA
    Speakers or Advisory Board
    : Merck, Genetech, Bristol-Meyers Squibb, Syndax, AstraZeneca, Celgene, Amgen Oncology
    Supported/Contracted Research/Grant: Medimmune, AstraZeneca, Bristol-Meyers Squibb
    Other Relationships: Celgene, Eli Lilly, MedImmune, AstraZeneca, Bristol-Meyers Squibb
  • Edward Garon, USA
    Speakers or Advisory Board:
     AstraZeneca, Bristol-Meyers Squibb, Eli Lilly, Genetech, Merck, Novartis, Pfizer, Boehringer Ingelheim, Mirati, Dynavax
    Supported/Contracted Research/Grant: Merck, Genentech, AstraZeneca, Novartis, Pfizer, Eli Lilly, Bristol-Meyers Squibb, Boehringer Ingelheim, Mirati Therapeutics, Dyanvax
    Other Relationships: Bristol-Meyers Squibb, Eli Lilly, AstraZeneca, Genentech, Merck, Novartis, Pfizer, Boehringer Ingelheim, Mirati, Dynavax
  • Rina Hui, Australia
    Honoraria:
     Bristol-Meyers Squibb, Boehringer Ingelheim, Merck, AstraZeneca, Novartis, Roche
    Speakers or Advisory Board: AstraZeneca, Merck, Novartis, Pfizer, Roche, Bristol-Meyers Squibb
    Other Relationships: Merck, AstraZeneca, Novartis, Roche, Bristol-Meyers Squibb, Boehringer Ingelheim, Pfizer
  • Rosalyn Juergens, Canada
    Honoraria:
     Bristol-Meyers Squibb, Merck, Roche, Boehringer Ingelheim, AstraZeneca, MedImmune, Eli Lilly, Takeda, Novartis, Amgen Pfizer
    Speakers or Advisory Board: Bristol-Meyers Squibb, Merck, Roche, Boehringer Ingelheim, Eli Lilly, Pfizer, Amgen, Novartis, AstraZeneca, Takeda
    Speakers Bureau: Amgen
    Supported/Contracted Research/Grant: AstraZeneca, MedImmune, Merck, Bristol-Meyers Squibb
    Other Relationships: Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Amgen, Roche, AstraZeneca, MedImmune
  • Martin Reck, Germany
    Honoraria
    : AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, Eli Lilly, Merck, Pfizer, Proacta, Novartis, Roche, Abbott
    Speakers or Advisory Board: Roche, Eli Lilly, AstraZeneca, Bristol-Meyers Squibb, Celgene, Merck, Boehringer Ingelheim, Novartis, Pfizer, Abbot
    Speakers Bureau: Roche, Eli Lilly, AstraZeneca, Bristol-Meyers Squibb, Celgene, Merck, Boehringer-Ingelheim, Novartis, Pfizer, Abbot
    Other Relationships: AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Lilly, Merck, Practa, Roche
  • Naiyer Rizvi, USA
    Honoraria:
     Roche, AstraZeneca, Novartis, Merck, Pfizer, Lilly, Bristol-Meyers Squibb
    Speakers or Advisory Board: Merck, AstraZeneca, Roche, Bristol-Meyers Squibb, Novartis, Pfizer, Eli Lilly, AbbVie, Regeneron
    Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds): Gritsone Oncology, Armo Biosciences
    Other Relationships: Merck, AstraZeneca, Roche, Bristol-Meyers Squibb, Novartis, Pfizer, Eli Lilly, AbbVie, Regeneron
  • Adrian Sacher, USA
    Nothing disclosed
  • Ross Soo, Singapore
    Honoraria:
     AstraZeneca, Bristol-Meyers Squibb, Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Pfizer, Celgene, Ignyta, Roche, Taiho
    Supported/Contracted Research/Grant: AstraZeneca
  • Yi-Long Wu, China
    Honoraria:
     AstraZeneca, Eli Lilly, Pfizer, Roche
    Speakers or Advisory Board: AstraZeneca, Roche, Pfizer, Eli Lilly, Boehringer Ingelheim, Sanofi
    Speakers Bureau: AstraZeneca, Roche, Boehringer Ingelheim, Eli Lilly, Pfizer, Sanofi
    Supported/Contracted Research/Grant: Boehringer Ingelheim, Roche
    Other Relationships: AstraZeneca, Boehringer Ingelheim, Merck, Roche
Interventional Diagnostics/Pulmonology
  • Kazuhiro Yasufuku, Chair, Canada
    Speakers or Advisory Board:
     Concordia, Olympus America
    Supported/Contracted Research/Grant: Olympus Corporation, Siemens, Veran Medical Technologies, Novadaq
    Other Relationships: Intuitive Surgical, Medtronic, Johnson & Johnson, Auris Surgical Robotics
  • Kwun Fong, Co-Chair, Australia
    Nothing disclosed
  • Jason Agulnik, Canada
    Honoraria: 
    Merck, Pfizer, Bristol-Meyers Squibb, AstraZeneca
  • Nicole Bouchard, Canada
    Speakers or Advisory Board:
     Bristol-Meyers Squibb, Merck, Roche
    Supported/Contracted Research/Grant: 
    Pfizer, Bristol-Meyers Squibb, Merck
  • Eric Edell, Canada
    Nothing disclosed
  • Wael Hannah, Canada
    Nothing disclosed
  • Kwun Fong, Australia
    Nothing disclosed
  • Felix Herth, Germany
    Nothing disclosed
  • Hojoong Kim, Korea
    Nothing disclosed
  • Moishe Liberman, Canada
    Nothing disclosed
  • Navneet Singh, India
    Nothing disclosed
  • Egbert Smit, Netherlands
    Nothing disclosed
Mesothelioma
  • Anna Nowak, Chair, Australia
    Speakers or Advisory Board
    : Bayer, AstraZeneca, Sellas Life Sciences, Trizell, Boehringer Ingelheim, Epizyme, Roche, Merck
    Supported/Contracted Research/Grant: 
    AstraZeneca, Douglas Pharma
    Other Relationships: 
    AstraZeneca, Boehringer Ingelheim, Epizyme
  • Marc DePerrot, Canada
    Nothing disclosed
  • Paul Baas, Netherlands
    Nothing disclosed
  • Penelope Bradbury, Canada
    Honoraria: 
    AbbVie, Merck, Pfizer
  • David Carbone, USA
    Honoraria: 
    AbbVie, Adaptimmune, Agenus, Amgen, Ariad, AstraZeneca, Biocept, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, Foundation Medicine, Genentech, Roche, Gritstone, Guardant Health, Inovio, Merck, Novartis, Palobiofarma, Pfizer, prIME Oncology, Stemcentrx, Takeda
    Speakers or Advisory Board: AbbVie, Adaptimmune, Agenus, Amgen, Ariad, AstraZeneca, Biocept, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, EMD Serono, Inc, Foundation Medicine, Genentech, Roche, Gritstone, Guardant Health, Inovio, Merck, Novartis, Palobiofarma, Pfizer, prIME Oncology, Stemcentrx, Takeda
    Supported/Contracted Research/Grant: Merck, Bristol-Meyers Squibb
    Other Relationships: Genentech
  • John Cho, Canada
    Nothing disclosed
  • Laura Donohoe, Canada
    Nothing disclosed
  • Dean Fennell, United Kingdom
    Honoraria:
     AbbVie, Boehringer Ingelheim, Bayer, Bristol-Meyers Squibb, Epizyme, Roche, AstraZeneca
    Speakers or Advisory Board: 
    AbbVie, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Meyers Squibb, Clovis, Eli Lilly, Lab21, Oncos, Polaris, Bristol-Meyers Squibb, Epizyme, Roche
    Speakers Bureau:
    Boehringer Ingelheim, Roche, Bristol-Meyers Squibb, Merck, AstraZeneca
    Supported/Contracted Research/Grant: 
    Boehringer Ingelheim, Bergen Bio, Bayer, Bristol-Meyers Squibb, Pierre Fabre, Eli Lilly, Roche-Genentech, Astex
  • Seiki Hasegawa, Japan
    Nothing disclosed
  • Christopher Lee, Canada
    Nothing disclosed
  • Isabelle Opitz, Switzerland
    Nothing disclosed
  • Nick Pavlakis, Australia
    Speakers or Advisory Board: 
    Bristol-Meyers Squibb, Merck, Astra Zeneca, Roche, Novartis, Boehringer Ingelheim, Merck, Pfizer, Ipsen, Amgen
    Supported/Contracted Research/Grant: 
    Bayer
  • Kenneth Rosenzweig, USA
    Nothing disclosed
Nursing and Allied Professionals
  • Massey Nematollahi, Chair, Canada
    Nothing disclosed
  • Patricia Hollen, Co-Chair, USA
    Nothing disclosed
  • Beth Eaby-Sandy, USA
    Speakers Bureau: 
    Helsinn, Merck, AstraZeneca, Takeda
    Other Relationships: 
    Consultant- AbbVie
  • Kathleen Gamblin, USA
    Nothing disclosed
  • Maria Guerin, United Kingdom
    Honoraria:
    AstraZeneca
    Speakers or Advisory Board:
    AstraZeneca
  • Pippa Labuc, United Kingdom
    Nothing disclosed
  • Naz Nouriany, Canada
    Nothing disclosed
  • Dianne Zawisza, Canada
    Nothing disclosed
Oligometastatic NSCLC
  • David Palma, Chair, Canada
    Nothing disclosed
  • Joseph Salama, Co-Chair, USA
    Nothing disclosed
  • Hak Choy, USA
    Honoraria: 
    AstraZeneca, Merck
    Speakers Bureau: AstraZeneca
  • Laurie Gaspar, USA
    Nothing disclosed
  • Matthias Guckenberger, Switzerland
    Nothing disclosed
  • David Jones, USA
    Nothing disclosed
  • Mary Macneil, Canada
    Nothing disclosed
  • Boris Sepesi, USA
    Nothing disclosed
Pathology
  • Ming Tsao, Chair, Canada
    Honoraria:
     Merck, AstraZeneca, Bristol Myers Squibb, Pfizer, Roche, Ventana
    Speakers or Advisory Board: AstraZeneca, Pfizer, Merck, Roche, Ventana, Bristol Myers Squibb, AbbVie, Celgene
    Supported/Contracted Research/Grant: Merck, Pfizer, Roche, Ventana, AstraZeneca
  • Ignacio Wistuba, Co-Chair, USA
    Speakers or Advisory Board: 
    Genentech, Roche, Bristol-Myers Squibb, AstraZeneca/Medimmune, Pfizer, HTG Molecular, Asuragen, Merck, GlaxoSmithKline, Bayer
    Speakers Bureau: Pfizer, Boehringer Ingelheim, Merck, Bristol-Myers Squibb, Genentech, Roche
    Supported/Contracted Research/Grant: Genentech, Merck, OncoPlex Diagnostics, Myriad Genetics, HTG Molecular Diagnostics, Silicon Biosystems, Adaptimmune, Pfizer, MedImmune, DepArray, Bristol-Myers Squibb, Adaptive, Takeda, Amgen
    Other Relationships: Genentech, Roche, Eli Lilly, Bristol-Myers Squibb, Ariad, HTG Molecular Diagnostics, Asuragen, Pfizer, AstraZeneza, MedImmune
  • Alan Borczuk, USA
    Nothing disclosed
  • Lukas Bubendorf, Switzerland
    Nothing disclosed
  • Sanja Dacic, USA
    Honoraria: 
    Bristol-Meyers Squibb, AstraZeneca
    Speakers or Advisory Board: 
    Bristol-Meyers Squibb, Astra-Zeneca
  • David Hwang, Canada
    Honoraria: 
    Merck, Pfizer, Takeda
    Speakers or Advisory Board: 
    Merck
  • Keith Kerr, United Kingdom
    Speakers or Advisory Board: 
    AstraZeneca, Bristol Meyers Squibb, Merck, Roche, Pfizer
    Other Relationships: 
    Bristol-Meyers Squibb
  • Sylvie Lantuejoul, France
    Nothing disclosed
  • John Longshore, USA
    Speakers or Advisory Board: 
    Roche, AbbVie, AstraZeneca, Bristol-Meyers Squibb, Merck, Pfizer
    Speakers Bureau: 
    Roche, AstraZeneca, Bristol-Meyers Squibb, Merck, Genentech
    Supported/Contracted Research/Grant: 
    Roche, AstraZeneca
  • Mari Mino-Kenudson, USA
    Honoraria: 
    Merrimac Pharmas, H3 Biomedicine
    Other Relationships: 
    Merrimac Pharmas, H3 Biomedicine
  • Andre Moreira, USA
    Nothing disclosed
  • Andrew Nicholson, United Kingdom
    Speakers or Advisory Board: 
    Pfizer, Abbvie
    Supported/Contracted Research/Grant: 
    Pfizer, Roche
    Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds): 
    Merck
    Other Relationships: 
    Merck, Boehringer Ingelheim, Novartis, AstraZeneca, Bristol-Meyers Squibb, Roche, AbbVie 
  • Yasushi Yatabe, Japan
    Honoraria: 
    AstraZeneca, Merck, Bristol Myers, Chugai-pharma, Pfizer, Roche
    Other Relationships: Merck, Chugai-Pharma, AstraZeneca, Bristol-Meyers Squibb, Pfizer, Roche, ThermoFisher, Dako
Prevention and Tobacco Control
  • Matthew Steliga, Chair, USA
    Nothing disclosed
  • Michael Cummings, Co-Chair, USA
    Nothing disclosed
  • Eric Bedard, Canada
    Nothing disclosed
  • Wanda De Kanter, Netherlands
    Nothing disclosed
  • Carolyn Dresler, USA
    Nothing disclosed
  • Rayjean Hung, Canada
    Nothing disclosed
  • Jacek Jassem, Poland
    Nothing disclosed
  • Jamie Ostroff, USA
    Nothing disclosed
  • Emily Stone, Australia
    Nothing disclosed
  • Nise Yamaguchi, Brazil
    Nothing disclosed
  • Li Zhang, China
    Speakers or Advisory Board: 
    Merck, Boehringer Ingelheim
Screening and Early Detection
  • Christine Berg, Chair, USA
    Honoraria: 
    Medial Early Sign LLC, GRAIL
  • Stephen Lam, Co-Chair, Canada
    Nothing disclosed
  • Denise Aberle, USA
    Nothing disclosed
  • John Field, United Kingdom
    Speakers or Advisory Board: 
    Epigenomics, VisonGate
    Speakers Bureau: 
    Roche
  • John Goffin, Canada
    Nothing disclosed
  • Harry Groen, Netherlands
    Other Relationships: 
    Roche-Genentech, Merck, Novartis, Bristol-Meyers Squibb
  • Norihiko Ikeda, Japan
    Honoraria: 
    AstraZeneca, Chugai, Merck, Ono Pharma, Taiho, Eli Lilly, Pfizer, Johnson & Johnson
  • Garth Nicholas, Canada
    Nothing disclosed
  • Nir Peled, Israel
    Honoraria: 
    AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Roche, NovellusDx, FMI, Gaurdant360
    Other Relationships: AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Roche, NovellusDx, FMI, Gaurdant360
  • Heidi Schmidt, Canada
    Nothing disclosed
  • Betty Tong, USA
    Speakers or Advisory Board: 
    Medtronic
Small Cell Lung Cancer/NET
  • Fiona Blackhall, Chair, United Kingdom
    Nothing disclosed
  • Peter Ellis, Co-Chair, Canada
    Honoraria:
     AbbVie, AstraZeneca
    Other Relationships:
     Celgene, Mylan
  • Jeffrey Bogart, USA
    Nothing disclosed
  • Lauren Byers, USA
    Nothing disclosed
  • Quincy Chu, Canada
    Nothing disclosed
  • Eric Lim, United Kingdom
    Speakers Bureau: 
    Abbott Molecular, Pfizer, Roche, Eli Lily, Boehringer Ingelheim, Ethicon
    Supported/Contracted Research/Grant:
     Medela, ScreenCell, Clearbridge Biomedics, Illumina, Guardant Health
  • Francoise Mornex, France
    Nothing disclosed
  • Charles Rudin, USA
    Speakers or Advisory Board: 
    AbbVie, Amgen, AstraZeneca, Bristol-Meyers Squibb, Genentech, Harpoon, Genetics
    Other Relationships: Bristol-Meyers Squibb, AbbVie, Seattle Genetics, Harpoon Therapeutics, Genentech Roche, AstraZeneca
  • Ben Slotman, Netherlands
    Nothing disclosed
  • Sumitra Thongprasert, Thailand
    Nothing disclosed
  • Jie Wang, China
    Nothing disclosed
  • Mauro Zukin, Brazil
    Nothing disclosed
Targeted Therapy
  • Janessa Laskin, Chair, Canada
    Honoraria:
     Roche, Boehringer Ingelheim, AstraZeneca
    Supported/Contracted Research/Grant: 
    AstraZeneca, Roche, Pfizer
  • Tony Mok, Co-Chair, China
    Honoraria: 
    AstraZeneca, Roche, Genentech, Pfizer, Eli Lilly, Boehringer Ingelheim, Merck, Novartis, SFJ Pharma, ACEA Biosciences, Vertex Pharma, Bristol-Meyers Squibb, OncoGenex Pharma, Celgene, Ignyta, Fishawack Facilitate, Takeda Oncology, Janssen, Cirina, Chimed
    Speakers or Advisory Board: 
    AstraZeneca, Roche, Genentech, Pfizer, Eli Lilly, Boehringer Ingelheim, Merck, Novartis, Bristol-Meyers Squibb, Taiho, Takeda Oncology Serono, SFJ Pharma, ACEA Biosciences, Vertex Pharma, geneDecode, OncoGenex Technologies, Celgene, Ignyta, Cirina, Fishawack Facilitate, Janssen, ChiMed
    Supported/Contracted Research/Grant: 
    AstraZeneca, Boehringer Ingelheim, Pfizer, Novartis, SFJ Pharmas Group, Roche, Merck, Clovis Oncology, Bristol-Meyers Squibb, Taiho Pharma, Eisai
    Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds): 
    Sanomics, Cirina
    Employee (full time or part time): The Chinese University of Hong Kong
    Other Relationships: Roche., IASLC, ASCO, ChiMed, Chinese Lung Cancer Research Foundation, Chinese Society of Clinical Oncology, Hong Kong Cancer Therapy Society
  • David Ross Camidge, USA
    Honoraria: 
    Takeda, G1 Therapeutics, Mersana Therapeutics, Roche, Genentech, AstraZeneca, Arrys/Kyn, Genoptix, Ignyta, Daichii Sankyo, Hansoh SRC, Bio-Thera, Lycera, Revolution Med, Orion, Clovis, Celgene, Novartis
    Speakers or Advisory Board: AstraZeneca, Takeda, Arrys/Kyn, Genoptix, G1 Therapeutics, Mersana Therapeutics, Roche, Genentech, Takeda, Ignyta, Daichii Sankyo, Hansoh SRC, Bio-Thera DSMB, Lycera, Revolution Med
    Supported/Contracted Research/Grant: Ariad, Takeda, Pfizer
  • Alexander Drilon, USA
    Honoraria: 
    TP Therapeutics, Loxo, Ignyta, Roche, Genentech, Pfizer
    Speakers or Advisory Board: Ignyta, Loxo, TP Therapeutics, AstraZeneca, Pfizer, Blueprint Medicines, Genentech, Roche, Takeda, Helsinn Therapeutics, BeiGene
    Supported/Contracted Research/Grant: Foundation Medicine
    Other Relationships: Ignyta, Loxo, TP Therapeutics, AstraZeneca, Pfizer, Blueprint Medicines, Genentech, Roche, Takeda, Helsinn Therapeutics, BeiGene
  • Enriqueta Felip, Spain
    Speakers or Advisory Board: 
    Boehringer Ingelheim, Eli Lilly, Pfizer, Roche, AstraZeneca, Bristol-Meyers Squibb, Novartis, AbbVie, Takeda, Celegene, Guardant Health, Merck
    Speakers Bureau: AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, MSD, Novartis, Pfizer, Roche, Takeda, AbbVie, Merck, Celegne, Eli Lilly, Guardant Health
    Other Relationships: AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb Celgene, Eli Lilly, Guardant Health, Novartis, Pfizer, Roche, Takeda, Merck
  • Pilar Garrido, Spain
    Speakers Bureau:
     Roche, Merck, Bristol-Meyers Squibb, Pfizer
    Supported/Contracted Research/Grant: Guardant
    Other Relationships: Roche, Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Bristol-Meyers Squibb, Eli Lilly and Company, AbbVie, Novartis
  • Shun Lu, China
    Speakers or Advisory Board: 
    Eli Lilly, Hutchison MediPharma, Simcere, Bristol-Meyers Squibb, Roche, Pfizer, AstraZeneca
    Supported/Contracted Research/Grant: 
    AstraZeneca
  • Zofia Piotrowska, USA
    Honoraria: 
    Guardant Health
    Speakers or Advisory Board: 
    AstraZeneca, Ariad, Takeda, Novartis, Boehringer Ingelheim, AbbVie
    Supported/Contracted Research/Grant: 
    Novartis
    Other Relationships: 
    AstraZeneca, Boehringer Ingelheim, Ariad, Novartis, Guardant Health, Takeda, AbbVie
  • Karen Reckamp, USA
    Supported/Contracted Research/Grant: 
    Bristol-Meyers Squibb, Pfizer, Novartis, Ariad, Clovis Oncology, Xcovery, Gilead Sciences, Pfizer, Adaptimmune, Genentech, Roche, Boehringer Ingelheim, AbbVie
    Other Relationships: 
    Amgen, Ariad, Astellas Pharma, Euclises, Tesaro, Boehringer Ingelheim, Takeda
  • Lecia Sequist, USA
    Speakers or Advisory Board: 
    AstraZeneca, Genentech, Pfizer, Bristol-Meyers Squibb, Merrimack Pharma, Blueprint Medicines
    Supported/Contracted Research/Grant: 
    AstraZeneca, Novartis, Genentech, Boehringer Ingelheim, Merck, Merrimack, Guardant Health
    Other Relationships: 
    Merrimack, Novartis, Boehringer Ingelheim
  • Ben Solomon, Australia
    Honoraria: 
    Bristol-Myers Squibb, AstraZeneca
    Speakers or Advisory Board: 
    AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer, Roche, Genentech, Novartis
    Supported/Contracted Research/Grant: 
    Pfizer
    Royalty, Intellectual Property/Patent Holder: 
    Veristrat
    Other Relationships: 
    AstraZeneca, Roche, Merck, Bristol-Myers Squibb, Novartis
  • James Yang, Taiwan
    Honoraria: 
    Novartis, Roche, Genentech, Eli Lilly and Company, Merck, Celgene, Pfizer, Ono Pharma, Bristol-Myers Squibb, Hansoh, Takeda, Boehringer Ingelheim, Astellas, Merimack, Yuhan Pharma
    Speakers or Advisory Board: 
    Boehringer Ingelheim, Eli Lilly, Roche, Genentech, Chugai, Astellas, Merck, Pfizer, Novartis, Takeda, Celgene, Merrimack, Yuhan Pharma, Bristol-Meyers Squibb, Ono Pharma, Daiichi Sankyo, AstraZeneca, Hansoh Pharma
    Other Relationships: 
    Boehringer Ingelheim, Eli Lilly, Bayer, Roche, Genentech, Chugai, Astellas, Merck, Novartis, Celgene, Merrimack, Yuhan Pharma, Bristol-Meyers Squibb, Ono Pharma, Daiichi Sankyo, Takeda, AstraZeneca, Hansoh Pharma
Thymoma/Other Thoracic Malignancies
  • Heather Wakelee, Chair, USA
    Honoraria: 
    ACEA, Genentech, Novartis, AstraZeneca
    Speakers or Advisory Board: 
    ACEA Biosyciences, Pfizer, Novartis, Genentech, Roche, AstraZeneca, Merck
    Supported/Contracted Research/Grant: 
    Clovis, Exelixis, AstraZeneca, MedImmune, Genentech, Roche, Bristol-Meyers Squibb, Gilead, Novartis, Xcovery, Pfizer, Celgene, Pharmacyclics, Eli Lilly, Acea, Merck
  • Meinoshin Okumura, Co-Chair, Japan
    Nothing disclosed
  • Anthony Brade, Canada
    Speakers or Advisory Board: 
    AstraZeneca
    Other Relationships: 
    Eli Lilly
  • Wentao Fang, China
    Nothing disclosed
  • Pier Luigi Filosso, Italy
    Nothing disclosed
  • Nicolas Girard, Canada
    Other Relationships: 
    Bristol-Meyers Squibb, Merck Roche, AstraZeneca
  • Shaf Keshavjee, Canada
    Nothing disclosed
  • Robert Korst, USA
    Nothing disclosed
  • Andreas Rimner, USA
    Honoraria: 
    Varian Medical Systms, Bristol-Meyers Squibb, AstraZeneca, Pfizer, Merck
    Speakers or Advisory Board: 
    AstraZeneca, Merck
    Supported/Contracted Research/Grant: 
    Varian Medical Systems, Boehringer Ingelheim, AstraZeneca, Pfizer
  • David Waller, United Kingdom
    Nothing disclosed
Treatment in the Real World - Support, Survivorship, Systems Research
  • Meredith Giuliani, Chair, Canada
    Nothing disclosed
  • Martin Stockler, Co-Chair, Australia
    Supported/Contracted Research/Grant: 
    AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Meyers Squibb, Celgene, Merck, Pfizer, Roche
  • Carlos Barrios, Brazil
    Honoraria: 
    Novartis, Roche, Genentech, Pfizer, GlaxoSmithKline, Sanofi, Boehringer Ingelheim, Eisai
    Supported/Contracted Research/Grant: 
    Pfizer, Novartis, Amgen Inc., AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Roche, Genentech, Eli Lilly, Sanofi, Taiho Pharma, Mylan, Merrimack, Merck, AbbVie, Astellas Pharma, Biomarin, Bristol-Meyers Squibb, Daiichi Sankyo, Abraxis BioScience, AB Science, Asana Biosciences, Medivation, Exelixis, ImClone Systems, Leo Pharma, Millennium
    Other Relationships: 
    Boehringer Ingelheim, Roche, Genentech, Novartis, GlaxoSmithKline, Eisai, Pfizer
  • David Dawe, Canada
    Nothing disclosed
  • William Evans, Canada
    Speakers or Advisory Board: 
    AbbVie, Astellas, Bristol-Meyers Squibb, Eisai, Eli Lilly, Janseen, Gilead, Takeda, AstraZeneca, Janssen, Boehringer Ingelheim, Roche, Celgene
    Other Relationships: AstraZeneca, Janssen, Boehringer Ingelheim, Roche, Celgene
  • David Gerber, USA
    Speakers or Advisory Board: 
    Bristol-Meyers Squibb, Samsung-Bioepis
    Speakers Bureau:
     Guardant
    Supported/Contracted Research/Grant: 
    Karyopharm, BerGenBio
    Ownership Interest (stocks or stock options, or other ownership interest Excluding diversified mutual funds): 
    Gilead
    Other Relationships: 
    Karyopharm
  • Cheryl Ho, Canada
    Honoraria: 
    AstraZeneca
    Supported/Contracted Research/Grant: BC Cancer Foundation
    Other Relationships: Roche
  • Ronan Kelly, USA
    Nothing disclosed
  • Biniam Kidane, Canada
    Nothing disclosed
  • Gilberto Lopes, Brazil
    Nothing disclosed
  • Alex Louie, Canada
    Honoraria: 
    Varian Medical Systems, AstraZeneca
  • Jarushka Naidoo, USA
    Supported/Contracted Research/Grant: 
    Merck, AstraZeneca
    Other Relationships: 
    Bristol-Meyers Squibb, Takeda, AstraZeneca
  • Taofeek Owonikoko, USA
    Speakers or Advisory Board: 
    AbbVie, Bristol-Meyers Squibb, G1 Therapeutics
    Supported/Contracted Research/Grant: Bristol-Meyers Squibb, AbbVie, United Pharma, G1 Therapeutics
  • Sadeesh Srinathan, Canada
    Nothing disclosed
Treatment of Early Stage/Localized Disease
  • Hisao Asamura, Chair, Japan
    Honoraria: 
    Lecturer of seminar - Johnson & Johnson, Covidien, Eli Lilly, Taiho, Boehringer Ingelheim, Ono Pharmaceuticals
  • Patrick Cheung, Co-Chair, Canada
    Nothing disclosed
  • Thomas D'Amico, USA
    Other Relationships:
     Consultant for Scanlan Instruments
  • Jessica Donington, USA
    Honoraria:
     AstraZeneca
  • Janet Edwards, Canada
    Nothing disclosed
  • Bob Li, USA
    Speakers or Advisory Board:
     Genentech, Guardant Health, Mersana Therapeutics
    Other Relationships: Genentech, Roche, Thermo Fischer Scientific, Guardant Health
  • Tetsuya Mitsudomi, Japan
    Speakers or Advisory Board:
     Eli LIlly
    Speakers Bureau:
     AstraZeneca, Chug, Pfizer, Boehringer Ingelheim
    Supported/Contracted Research/Grant: 
    Eli Lilly, Boehringer Ingelheim, AstraZeneca, Chugai, The Japan Society for the Promotion of Science
    Other Relationships: AstraZeneca, Chug, Pfizer, Boehringer Ingelheim
  • Luis Raez, USA
    Supported/Contracted Research/Grant:
     Bristol-Meyers Squibb, Pfizer, Roche, Genentech, Syndax, Novartis
  • Ramon Rami-Porta, Spain
    Nothing disclosed
  • Tomohito Saito, Japan
    Supported/Contracted Research/Grant: 
    Ono Pharma, Bristol-Myers Squibb
    Other Relationships: 
    Ono Pharma
  • Suresh Senan, Netherlands
    Honoraria: 
    Eli Lilly
    Speakers or Advisory Board: 
    AstraZeneca, Eli Lilly, Merck
    Supported/Contracted Research/Grant: 
    Varian Medical Systems, ViewRay
    Employee (full time or part time): 
    VU University Medical Center
Treatment of Locoregional Disease - NSCLC
  • Corinne Faivre-Finn, Chair, United Kingdom
    Honoraria: AstraZeneca, Merck
    Speakers or Advisory Board:
     Pfizer, Merck
    Speakers Bureau: AstraZeneca, Merck
    Supported/Contracted Research/Grant: Merck, AstraZeneca, Elekta
    Other Relationships: Merck, AstraZeneca, Elekta, Pfizer, Respective Meeting-Related Travel Support
  • Paula Ugalde, Co-Chair, Canada
    Nothing disclosed
  • Charles Butts, Canada
    Honoraria: 
    Pfizer, Boehringer Ingelheim, AstaZeneca, Bristol-Meyers Squibb, Merck, Takeda
    Speakers or Advisory Board: Pfizer, AstraZeneca, Boehringer Ingelheim, Bristol-Meyers Squibb, Merck, Takeda
  • Hiroshi Date, Japan
    Nothing disclosed
  • Dirk de Ruysscher, Netherlands
    Nothing disclosed
  • Rui Haddad, Brazil
    Nothing disclosed
  • Feng-Ming (Spring) Kong, USA
    Honoraria: 
    Varian Medical
    Speakers Bureau: 
    Varian Medical
  • Jocelyne Martin, Canada
    Nothing disclosed
  • Renato Martins, USA
    Nothing disclosed
  • Harvey Pass, USA
    Nothing disclosed
  • Gaetano Rocco, Italy
    Speakers Bureau: 
    Baxter, Medtronic
  • Eric Vallieres, USA
    Speakers or Advisory Board: 
    AbbVie, AstraZeneca, Spiration
    Speakers Bureau: Synthes
    Other Relationships: Spiration, Olympus
Young Investigator Track
  • Benjamin Besse, Chair, France
    Supported/Contracted Research/Grant: 
    Roche, AstraZeneca
  • Jonathan Yeung, Co-Chair, Canada
    Nothing disclosed
  • Clarissa Baldotto, Brazil
    Nothing disclosed
  • Vladmir de Lima, Brazil
    Nothing disclosed
  • Mark Doherty, Canada
    Nothing disclosed
  • Yoshihisa Kobayashi, Japan
    Speakers Bureau: 
    Boehringer Ingelheim
    Supported/Contracted Research/Grant: The Japan Society for the Promotion of Science, Osaka Cancer Society, Novartis
  • Celine Mascaux, France
    Honoraria: 
    Boehringer Ingelheim, Eli Lilly, Bristol-Meyers Squibb, Roche, AstraZeneca
    Speakers or Advisory Board: 
    AstraZeneca, Roche, Kephren
    Other Relationships: Roche, Kephren, AstraZeneca, Merck
  • Tatiane Montella, Brazil
    Nothing disclosed
  • Luis Ubillos, Uruguay
    Speakers or Advisory Board: 
    Roche, Tecnofarma, Servier, Bayer
    Speakers Bureau: 
    Roche, Tecnofarma
  • Linda Coate, USA
    Nothing disclosed